Warning! GuruFocus detected
3 Severe warning signs
with TCF.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
TheraCryf PLC
ISIN : GB00BSVYN304
Description
TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.85 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -12.04 | |||||
| Beneish M-Score | 8.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 14.8 | |||||
| 3-Year EPS without NRI Growth Rate | 15.1 | |||||
| 3-Year FCF Growth Rate | 18.1 | |||||
| 3-Year Book Growth Rate | -40.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 54.56 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.93 | |||||
| 9-Day RSI | 14.57 | |||||
| 14-Day RSI | 21.63 | |||||
| 3-1 Month Momentum % | -47.62 | |||||
| 6-1 Month Momentum % | -63.33 | |||||
| 12-1 Month Momentum % | -68.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.36 | |||||
| Quick Ratio | 4.36 | |||||
| Cash Ratio | 2.57 | |||||
| Days Sales Outstanding | 373.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -18.8 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -898.99 | |||||
| Net Margin % | -792.17 | |||||
| FCF Margin % | -785.61 | |||||
| ROE % | -98.04 | |||||
| ROA % | -83.14 | |||||
| ROIC % | -376.73 | |||||
| 3-Year ROIIC % | -176.94 | |||||
| ROC (Joel Greenblatt) % | -1072.89 | |||||
| ROCE % | -112.42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.25 | |||||
| PB Ratio | 0.38 | |||||
| EV-to-EBIT | -1.07 | |||||
| EV-to-Forward-EBIT | -0.48 | |||||
| EV-to-EBITDA | -1.08 | |||||
| EV-to-Forward-EBITDA | -0.5 | |||||
| EV-to-Revenue | 9.07 | |||||
| EV-to-Forward-Revenue | 2.36 | |||||
| EV-to-FCF | -1.15 | |||||
| Price-to-Net-Current-Asset-Value | 0.23 | |||||
| Earnings Yield (Greenblatt) % | -93.46 | |||||
| FCF Yield % | -64.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TheraCryf PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 0.396 | ||
| EPS (TTM) (£) | -0.009 | ||
| Beta | 3.09 | ||
| 3-Year Sharpe Ratio | -0.39 | ||
| 3-Year Sortino Ratio | -0.64 | ||
| Volatility % | 44.3 | ||
| 14-Day RSI | 21.63 | ||
| 14-Day ATR (£) | 0.000535 | ||
| 20-Day SMA (£) | 0.002315 | ||
| 12-1 Month Momentum % | -68.57 | ||
| 52-Week Range (£) | 0.002 - 0.0125 | ||
| Shares Outstanding (Mil) | 2,129.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TheraCryf PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TheraCryf PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| No Event Data | ||||
TheraCryf PLC Frequently Asked Questions
What is TheraCryf PLC(LSE:TCF)'s stock price today?
The current price of LSE:TCF is £0.00. The 52 week high of LSE:TCF is £0.01 and 52 week low is £0.00.
When is next earnings date of TheraCryf PLC(LSE:TCF)?
The next earnings date of TheraCryf PLC(LSE:TCF) is 2025-05-28 Est..
Does TheraCryf PLC(LSE:TCF) pay dividends? If so, how much?
TheraCryf PLC(LSE:TCF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers